cagrisema phase 3 results 2025 semaglutide cagrilintide obesity 2024 Three new REIMAGINE studies provide some of the Novo Nordisk's next-gen obesity drug

Our physicians stay current on the science and translate it into safe, effective treatment plans for each patient

In clinical trials, hair loss was reported in 3-5% of patients using GLP-1 medications compared to just 1% using placebo

However, exenatide does not affect the normal response of glucagon or other hormones to hypoglycemia

Diabetic Ketoacidosis: If you have diabetic ketoacidosis, Ozempic is not recommended

Semaglutide has been shown to have cardiovascular benefits, but monitoring remains crucial

Unlike other weight loss supplements that rely on harsh stimulants, L-Carnitine works naturally with your bodys processes, making it a safe and effective choice for long-term results